FMR CORP 13D and 13G filings for Relay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-10 10:20 am Sale |
2023-07-07 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 2,956,221 2.430% |
-6,777,627 (-69.63%) |
Filing |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 9,733,848 8.051% |
-2,224,364 (-18.60%) |
Filing |
| 2022-10-11 09:03 am Sale |
2022-10-07 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 11,958,212 9.947% |
-4,248,389 (-26.21%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 16,206,601 14.999% |
5,844,601 (+56.40%) |
Filing |
| 2021-07-12 12:07 pm Purchase |
2021-07-09 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 10,362,000 11.216% |
5,599,762 (+117.59%) |
Filing |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Relay Therapeutics, Inc. RLAY |
FMR CORP | 4,762,238 5.292% |
4,762,238 (New Position) |
Filing |